Author Correction: Cyclin-dependent kinase 12 is a drug target for visceral leishmaniasis (Nature, (2018), 560, 7717, (192-197), 10.1038/s41586-018-0356-z)

Research output

Research output per year 2018 2018 2018

• 1 Article

Research output per year

Research output per year

Search results

• 2018

  Cyclin-dependent kinase 12 is a drug target for visceral leishmaniasis

  Wyllie, S., Thomas, M., Patterson, S., Crouch, S., De Rycker, M., Lowe, R., Gresham, S., Urbaniak, M. D., Otto, T. D., Stojanovski, L., Simeons, F. R. C., Manthri, S., MacLean, L. M., Zuccotto, F., Homeyer, N., Pflaumer, H., Boesche, M., Sastry, L., Connolly, P. & Albrecht, S. & 12 others, Berriman, M., Drewes, G., Gray, D. W., Ghidelli-Disse, S., Dixon, S., Fiandor, J. M., Wyatt, P. G., Ferguson, M. A. J., Fairlamb, A. H., Miles, T. J. (Lead / Corresponding author), Read, K. D. (Lead / Corresponding author) & Gilbert, I. H. (Lead / Corresponding author), 9 Aug 2018, In: Nature. 560, 7717, p. 192-197 6 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  File

  • Drug Target 100%
  • Visceral Leishmaniasis 100%
  • Cyclin-dependent Kinase 12 100%
  • Cyclin Dependent Kinase 100%
  • Further Development 25%
  120 Citations (Scopus)

  892 Downloads (Pure)